EN | TR
E-ISSN: 2147-2653
The Relationship Between Vitamin D Levels and the Quality of Life in Patients with Alopecia Areata and Vitiligo
PDF
Cite
Share
Request
Original Investigation
VOLUME: 25 ISSUE: 1
P: 35-39
April 2019

The Relationship Between Vitamin D Levels and the Quality of Life in Patients with Alopecia Areata and Vitiligo

Turk J Osteoporos 2019;25(1):35-39
DOI: 10.4274/tod.galenos.2019.19327
Nazlı Dizen Namdar 1
İnci Arıkan 2
1. Kütahya Sağlık Bilimleri Üniversitesi Tıp Fakültesi, Dermatoloji Anabilim Dalı, Kütahya, Türkiye
2. Kütahya Sağlık Bilimleri Üniversitesi Tıp Fakültesi, Halk Sağlığı Anabilim Dalı, Kütahya, Türkiye
No information available.
No information available
Received Date: 23.12.2018
Accepted Date: 04.03.2019
Publish Date: 25.04.2019
PDF
Cite
Share
Request

ABSTRACT

Objective:

In this study, it was aimed to investigate the relationship between vitamin D and the quality of life in patients with alopecia areata (AA) and vitiligo.

Materials and Methods:

The study group includes 60 patients with AA, 44 patients with vitiligo and 61 patients with control group. Sociodemographic and clinical features of study group and vitamin D levels of all participants were recorded. According to the records, it was evaluated as vitamin D deficiency for 25(OH)D level under 20 ng/mL, vitamin D insufficiency for 20-29 ng/mL and normal level for equal to and over 30 ng/mL. Patients were requested to fill out the dermatology life quality index (DLQI) questionnaire.

Results:

In our study, the vitamin D level of the patient group was found lower than the control group (p<0.000). Vitamin D levels and DLQI scores were negatively correlated in patients with AA and it was significant (p=0.012). In patients with vitiligo, no significant relationship was found between the DLQI scores and vitamin D levels (p=0.066).

Conclusion:

Vitamin D deficiency is quite common in patients with AA and vitiligo. The quality of life was impaired in both diseases. Especially in patients with AA, quality of life impairs as vitamin D levels decrease. In patients with AA which detected deficient or insufficient vitamin D, we believe that vitamin D supplementation can improve the quality of life, and thus contribute to the treatment of these patients.

References

1
Oğrum A, Boyraz N, Karataş-Toğral A, Karasatı S, Ekşioğlu HM. Alopesi areatalı hastalarda 25 hidroksi vitamin D3 düzeyinin değerlendirilmesi. Türkderm 2015;49:50-3.
2
Abedini R, Hallaji Z, Lajevardi V, Nasimi M, Khaledi MK, Tohidinik HR. Quality of life in mild and severe alopecia areata patients. International Journal of Women’s Dermatology 2018;4:91-4.
3
Erfan G, Albayrak Y, Yanık ME, Oksuz O, Tasolar K, Topcu B, et al. Distinct temperament and character profiles in first onset vitiligo but not in alopecia areata. J Dermatol 2014;41:709-15.
4
AlGhamdi K, Kumar A, Moussa N. The role of vitamin D in melanogenesis with an emphasis on vitiligo. Indian J Dermatol Venereol Leprol 2013;79:750-8.
5
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208-14.
6
Acıöz E, Gökdemir G, Köşlü A. Dermatolojide yaşam kalitesi. TÜRKDERM 2003;37:16-23
7
Akpınar P, İçağasıoğlu A. D Vitamininin Yaşam Kalitesi İle İlişkisi. Türk Osteoporoz Dergisi 2012;18:13-8.
8
Fidan F, Alkan BM, Tosun A. Çağın Pandemisi: D Vitamini Eksikliği ve Yetersizliği Türk Osteoporoz Dergisi 2014:20:71-4.
9
Chao YS, Ekwaru JP, Ohinmaa A, Griener G, Veugelers PJ. Vitamin D and health-related quality of life in a community sample of older Canadians. Qual Life Res 2014;23:2569-75.
10
Huang W, Shah S, Long Q, Crankshaw AK, Tangpricha V. Improve¬ment of pain, sleep, and quality of life in chronic pain patients with vi¬tamin D supplementation. Clin J Pain 2013;29:341-7.
11
Krul-Poel YH, Westra S, Van Wijland HJ, Stam F, Lips P, Pouwer F, et al. Vitamin D status and health-related quality of life in patients with Type 2 diabetes 2016;33:300-6.
12
Kim JS, Choi YE, Baek JK, Cho HJ, Kim YS. The Association between Vitamin D and Health-Related Quality of Life in Korean Adults. Korean J Fam Med 2016;37:221-7.
13
Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, et al. Alopecia areata investigational assessment guidelines-Part II. J Am Acad Dermatol 2004;51:440-447.
14
Finlay AY, Khan GK. Dermatology life quality index (dlqi)–a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
15
Oztürkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the turkish version of dermatology life quality index. Int J Dermatol 2006;45:1300-7.
16
Ghajarzadeh M, Ghiasi M, Kheirkhah S. Associations between Skin Diseases and Quality of Life: A Comparison of Psoriasis, Vitiligo, and Alopecia Areata. Acta Medica Iranica 2012;50:511-5.
17
Seongmin N, Kim M, Park CO, Hann SK, Oh SH. Comparison of the Psychological Impacts of Asymptomatic and Symptomatic Cutaneous Diseases: Vitiligo and Atopic Dermatitis. Ann Dermatol 2013;25:454-61.
18
Ongenae K, Dierckxsens L, Brochez L, Van Geel N, Naeyaert JM. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 2005;210:279-85.
19
Kent G, Al’Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996;21:330-3.
20
Qi S, Xu F, Sheng Y, Yang Q. Assessing quality of life in Alopecia areata patients in China. Psychol Health Med 2015;20:97-102.
21
Takcı Z, Tekin Ö, Ertuğrul DT, Karadağ AS, Akın KO. A case-control study: evaluation of vitamin D metabolism in patients with vitiligo. Turk J Med Sci 2015;45:837-41.
22
Saleh HM, Abdel-Fattah NS, Hamza HT. Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases. Photodermatol Photoimmunol Photomed 2013;29:34-40.
23
Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease?: A systematic review. Semin Arthritis Rheum 2011;40:512-31.
24
Aksu C, Sarikaya A, Solak S, Altunay KI. Vitamin D deficiency in alopecia areata. Br J Dermatol 2014;170:1299-304.
25
Yılmaz N, Serarslan G, Gokce C. Vitamin D concentrations are decreased in patients with alopecia areata. Vitam Trace Elem 2012;1:105-9.
26
Dovidio R, Vessio M, Dovidio FD. Reduced level of 25-hydroxyvitamin D in chronic/relapsing alopecia areata. Dermatoendocrinol 2013;5:271-3.
27
Erpolat S, Sarifakioglu E, Ayyildiz A. 25-hydroxyvitamin D status in patients with alopecia areata. Adv Dermatol Allergol 2017;34:248-52.
28
Ustun I, Seraslan G, Gokce C, Motor S, Can Y, Ugur Inan M, et al. Investigation of vitamin D levels in patients with vitiligo vulgaris. Acta Dermatovenerol Croat 2014;22:110-3.
29
Karagün E, Ergin C, Baysak S, Erden G, Aktaş H, Ekiz Ö. The role of serum vitamin D levels in vitiligo. Postepy Dermatol Alergol 2016;33:300-2.
30
Kim HJ, Lee JY, Kim TJ, Lee JW. Association between serum vitamin D status and health-related quality of life (HRQOL) in an older Korean population with radiographic knee osteoarthritis: data from the Korean national health and nutrition examination survey (2010–2011). Health Qual Life Outcomes 2015;13:48.
31
Schiller A, Apetrii M, Onofriescu M, Siriopol D, Veisa G, Schiller O, et al. Prognostic significance of 25-hydroxivitamin D entirely explained by a higher comorbidity burden: experience from a South-Eastern European dialysis cohort. Hemodial Int 2015;19:249-55.